Global Health Ltd |
|
Registered Office:
Medanta-Mediclinic,E-18 Defence Colony
,
New Delhi
-
110024
,
New Delhi
, India.
Phone :
91-124-4834060 Fax:
Email : compliance@medanta.org
Website : www.medanta.org
|
Initial public offering of 65,641,952* equity shares of face value of 2 each ("Equity Shares") of Global Health Limited (The "Company" or the "Company" or the "Issuer") for cash at a price of 336 per equity share (including a premium of 334 per equity share) (the "Offer Price") aggregating to 2205.57 crores* (the "Offer") comprising a fresh issue of 14,880,952* equity shares by the company aggregating up to 500.00 crores (the "Fresh Issue") and an offer for sale of 50,761,000 equity shares aggregating to 1705.57 crores* (the "Offer for Sale") comprising 50,661,000 equity shares aggregating to 1702.21 crores* by Anant Investments (the "Investor Selling Shareholder") and 100,000 equity shares aggregating to 3.36 crores* by Sunil Sachdeva (jointly held with Suman Sachdeva) (the "Individual Selling Shareholders", and along with investor selling shareholder, the "Selling Shareholders" and such equity shares offered by the selling shareholders, the "Offered Shares"). The offer shall constitute 24.46%* of the fully diluted post-offer paid-up equity share capital of the company.
The face value of the equity share is 2 each and the offer price is 168 times the face value of equity shares.
*Subject to finalization of the basis of allotment
Bids can be made for a minimum of 44 equity shares and in multi-les of 44 equity shares thereafter. |
Issue |
Money Payable On |
|
Opens On |
Closes On |
Application |
Allotment |
|
03-Nov-22 |
07-Nov-22 |
Rs336.00-0.00 |
Rs0.00-0.00 |
Minimum Application for shares in Nos :44 Further Multiples of :44 |
|
RsCr |
Lead Managers to the Issue |
|
Project Cost |
476.70 |
Credit Suisse Securities (India) Pvt Ltd |
|
Project Financed through Current Offer |
2205.57 |
|
Post Issue Equity Share Capital |
53.64 |
|
Issue Price |
Rs336.00 |
|
|